SOPRINJEC
Provides prototyping and plastic injection molding services for industrial parts, leveraging additive manufacturing (SLA, SLS, DMLS) to reduce lead times from weeks to days for functional prototypes.
- CEO / Founder
- SOPRINJEC GROUP
- Team Size
- 1-10
- Stage
- Active
Technology & Products
Key Products
Additive Manufacturing (SLA, SLS, DMLS); Plastic Injection Molding; Vacuum Casting; Machining (CNC); Tooling Design and Testing; 3D Modeling and Design
Technological Advantage
Proprietary integration of SLA, SLS, and DMLS processes with injection molding tooling reduces iteration cycles by 40% (claimed); no verified patents found, but trade secret in process optimization for multi-material prototypes.
Differentiation
Value Proposition
Offers end-to-end industrialization support from 3D file design to production, reducing prototyping costs by 30-50% and lead times from 6-8 weeks to 1-2 weeks through integrated AM and injection molding services.
How They Differentiate
Unlike pure-play AM service bureaus (e.g., Pollen AM), SOPRINJEC integrates injection molding tooling, offering 50% faster time-to-market for production-ready parts; compared to traditional molders, provides 3x faster prototyping via in-house SLA/SLS/DMLS.
Market & Competition
Target Customers
Manufacturers in aerospace, automotive, medical, IoT, and luxury sectors requiring rapid prototyping and low-volume production.
Industry Verticals
Aerospace; Automotive; Medical; IoT; Luxury; Appliance; Marketing; Leisure
Competitors
AdhesionXtreme SARL; Pollen AM Inc.; AS Industries; Marle Group
Growth & Milestones
Growth Metrics
The company employs 6 people and has a share capital of €7,500, reduced from €15,000 in December 2023.
Major Milestones
Founded in 2017; Listed in VoxelMatters AM directory as service provider; Partnership with LuxAI for robot parts development
Notable Customers
LuxAI